THIRD-PARTY PHARMACY RECONCILIATION

Size: px
Start display at page:

Download "THIRD-PARTY PHARMACY RECONCILIATION"

Transcription

1 THIRD-PARTY PHARMACY RECONCILIATION Billy Caster Sales Solution Expert Inmar Healthcare Network Jon Brumbaugh Sr. Manager, Product Inmar Healthcare Network

2 Session Description A discussion and presentation on how best-in-class reconciliation practices can align directly with the ever-changing industry. We will look at reconciliation from the perspective of the pharmacy, finance and managed care organizations These best practices are derived from our experience working with 21,000 pharmacies and processing more than 1.1 billion claims. 2

3 The Industry is Aligning Goals The triple aim Improving the health of populations Improving the experience of care Reducing per capita healthcare costs 3

4 Reconciliation must Align with Trends PHARMACY FINANCE Growth of Government Payers Narrow network revolution Pharmacists as care providers Lower patient pay Overall industry growth Consolidation (M&A and partnerships) Generic price inflation (GPI) Healthcare Reform RECONCILIATION Retail clinics Patient engagement and services Specialty pharmacy Value Based Healthcare / Quality initiatives MANAGED CARE 4

5 Your Organization must be Aligned with Reconciliation The Pharmacy The Finance Organization Managed Care Organization Best-in-class reconciliation involves streamlined processes, transparency and communication among your pharmacy, finance, managed care departments and more. 5

6 The Pharmacy Patient Engagement and Services Implement, adapt, and financially track services catered to patients as the industry moves to value-based reimbursement and lower patient pay. Capture all adjudication responses Capture non-rx claims Communicate pharmacy process problems That are costing you money (i.e., drug selection, re-adjudication and service fees) Hard and Soft Dispensing Stops (Pre and Post-Edit) To protect you financially need continuous review, incorporating feedback from the reconciliation/audit process SOP documentation Pharmacy reversals, prior authorization, step therapy and patient data 6

7 Pharmacy and the Industry Topics affecting Pharmacy: Lower patient payment More patient services (Retail clinics, MTM, etc) Specialty pharmacy Cost reduction efforts Narrow network revolution Exceptions / Collections business intelligence Medical services 7

8 Increased Role of Pharmacy As of 2014, there is Between $200B and $300B in avoidable healthcare costs. Pharmacy is becoming a formidable presence In 2010 (K): PA NPA PCP Pharmacist In 2020: 76 Pharmacists per 100K patients In 2014: There were 13B pharmacy visits in the U.S. each year, as opposed to 470M to physicians. Source: NACDS Total Store EXPO 2014, Convenient Care: Point-of-Care Testing in the Pharmacy. Alex Adams (NACDS), Michael Klepser (Ferris State University), Karen Mankowski (Meijer Inc.), Cheryl Miller and John Tamerius (Quidel Corporation) 8

9 The Finance Organization Know your numbers: How you compare, what they tell you and where you can take action. Increase profitability: View business by different areas of concentration and take action: AWP: Re-billing must funnel into the receivable. 340B: Must be cared for in the receivable. Brand vs. generic vs. specialty pharmaceutical impact Collaborative approach to reconciliation between the pharmacy, point of sale, accounting, managed care and more. Set up the most efficient processes for: POS reconciliation to the third-party receivable Weekly and monthly reporting/gl feeds Payment exception management Annual review of GL Codes that drive financial reporting and help glean opportunity areas. Annual review of business rules, write-off practices, etc. 9

10 Finance and the Industry Topics affecting finance / accounting: Higher third-party receivable from public funding, government payers Narrow Network Revolution Cost reductions efforts Lower Patient Pay Patient services, refunds, etc. Reimbursement rate decline Generic Price Inflation New Fees (Ex: DIR) EFT payments Audits 10

11 Changing payment dynamic Increase drug spending with a changing demographic of payment source: Pharmacies benefit from expected overall growth in prescription spending Public funds will eventually overtake employer-sponsored spending 12% 10% 78% Source of payment for outpatient pharmacy claim 2% 5% 23% 35% 11% 53% 44% 38% 16% 66% 48% 21% 37% 45% 26% 17% 12% Individually Purchased Employer Insurance Public Funds Consumer Outof-Pocket F Source: Pembroke Consulting, Economic Report on Retail, Mail, and Specialty Pharmacies January

12 Dispensed medications by payer 65.1% 2014: 4.4B Rx, $305B 57.0% Commercial Third-Party 19.0% 8.3% 7.5% 26.0% 10.0% 7.0% Medicare Part D Medicaid Cash Source: IMS Health, The 2014 U.S. Pharmaceutical Market: Trends, Issues, & Outlook. August 24,

13 Dispensed medications by payer 65.1% Since M+ new government scripts (382M Part D, 140 Medicaid) 68M+ less commercial 19.0% 8.3% 7.5% 2014: 4.4B Rx, $305B 57.0% 26.0% 10.0% 7.0% Commercial Third-Party Medicare Part D Medicaid Cash Source: IMS Health, The 2014 U.S. Pharmaceutical Market: Trends, Issues, & Outlook. August 24,

14 Dispensed medications by payer 65.1% Since M+ new govt. scripts (137M Part D, 41M Medicaid) $11.9B in govt. growth ($9.2B Part D, $2.7B Medicaid) $1.72B commercial shrinkage 19.0% 8.3% 7.5% 2014: 4.4B Rx, $305B 57.0% 26.0% 10.0% 7.0% Commercial Third-Party Medicare Part D Medicaid Cash Source: IMS Health, The 2014 U.S. Pharmaceutical Market: Trends, Issues, & Outlook. August 24,

15 The Managed Care Organization Know your numbers: How you compare, what they tell you and where you can take action. Use reconciliation data in pricing strategies and drug purchasing. Predict impact of industry changes: generic conversion, PBM mergers, product cost changes and more. Optimize payer relationships and contracts with value-added analytics and insight. Protect yourself from audits in contracts. Understand the financial scale of every contracting term. Solid audit management process to understand audit language in contracts, address all responses on time, effectively negotiate and reduce risk of future audits. 15

16 Managed Care and the Industry Topics affecting Managed Care: Value-based quality initiatives Patient Services Emerging Care Models and the Growth of Accountable Care Organizations (ACOs) Healthcare Reform Differing network design Adherence Audits 16

17 Emerging Care Models (ACOs/PCMHs) Accountable Care Organizations (ACOs): Collaborative, collective accountability for the cost and quality of care delivered Outpatient pharmacies are well positions to support ACOs: Patient Care Management and Education Compliance and Evidence-Based Care Minimization of Waste and Cost Containment Medication Reconciliation Patient Identification and Services Local Provider for Accountability, Efficiency, and Quality Pharmacists have the opportunity to leverage their services to influence patient outcomes that drive a number of specific ACO quality measures Source: NACDS Total Store Expo 2014: Emerging Care Models: Partnerships with Pharmacies to Drive Patient Outcomes. Mike Dull (Shop Store Operating Co., LLC) and Donald Klepser (University of Nebraska Medical Center) 17

18 The Positive Perception of ACOs Increase Prescribing of Generics and Biosimilars Increased Prescribing of Generics and Biosimilars mprove Prescribing Adherence to Evidence-Based Guidelines Improve Prescribing Adherence to Evidence-Based Guidelines Improve Overall Health Outcomes Improve Overall Health Outcomes Decrease Overal Healthcare Costs Decrease Overall Healthcare Costs Optimize Lowest Cost Site of Service Optimize Lowest Cost Site of Service Improve Coordination of Medication Reconciliation Improve Coordination of Medication Reconciliation Drive Improved Adherence Drive Improved Adherence Enable Value-Based Payment Reform Enable Value-Based Payment Reform Decrease Total Pharmacy Costs Decrease Total Pharmacy Costs 30% 59% 54% 54% 51% 49% 48% 46% 69% 0% 20% 40% 60% 80% Source: EMD Serono 2014 EMD Serono Specialty Digest, 10 th Edition,

19 Growth of ACOs and PCMHs 800 Accountable Care Organizations In 2014, there were more than 5000 Patient Centered Medical Homes (PCMH) Source: NACDS Total Store Expo 2014: Emerging Care Models: Partnerships with Pharmacies to Drive Patient Outcomes. Mike Dull (Shop Store Operating Co., LLC) and Donald Klepser (University of Nebraska Medical Center) 19

20 Best practices in new-age reconciliation Evergreen strategies Strong reimbursement exception management tools Price optimization Payer and reimbursement tracking Strategies for aligning reconciliation with the industry: Patient engagement and medication adherence programs Measure quality and value metrics Track the metrics that drive your business success Future Strategies Value-based reimbursement Quality adherence and outcomes Adapt and transition your strategies to create a sustainable business model. 20

21 Making it happen Need a Healthcare Network partner that can do these things: Reconciliation know your reimbursement metrics and peer benchmarking Contract management and modeling solution Audit tool that provides insights and preventive measures Customer / Patient analytics 21

22 Jon Brumbaugh Billy Caster

23

INDUSTRY TRENDS IN PHARMACY REIMBURSEMENT

INDUSTRY TRENDS IN PHARMACY REIMBURSEMENT INDUSTRY TRENDS IN PHARMACY REIMBURSEMENT Heather Shouse, Sr. Director, Healthcare Solutions/ Inmar Jon Brumbaugh, Sr. Manager, Product, Healthcare / Inmar Disclosure We have no relationships with commercial

More information

Pharmacy Benefit Management in Oncology

Pharmacy Benefit Management in Oncology Pharmacy Benefit Management in Oncology October 28 th, 2015 Business Health Care Group Protecting the Future of Oncology Care: A Community Conversation Brent Eberle RPh MBA Chief Pharmacy Officer, Navitus

More information

Challenges in High Dollar Drugs. Suzanne Francart, PharmD, BCPS Manager Infusion Services & Medication Assistance Program UNC HealthCare

Challenges in High Dollar Drugs. Suzanne Francart, PharmD, BCPS Manager Infusion Services & Medication Assistance Program UNC HealthCare Challenges in High Dollar Drugs Suzanne Francart, PharmD, BCPS Manager Infusion Services & Medication Assistance Program UNC HealthCare Disclosure I have no relevant conflicts of interest to disclose Learning

More information

CBI 4th Reimbursement and Contracting Conference: Key Challenges Related to Specialty Drug Pricing and Contracting

CBI 4th Reimbursement and Contracting Conference: Key Challenges Related to Specialty Drug Pricing and Contracting CBI 4th Reimbursement and Contracting Conference: Key Challenges Related to Specialty Drug Pricing and Contracting Avalere Health An Inovalon Company February 28, 2017 Growth in Drug Costs Relative to

More information

How ACO s Can Impact Contracting A Real World Example. Mike Medel Pharm D, MBA Banner Health

How ACO s Can Impact Contracting A Real World Example. Mike Medel Pharm D, MBA Banner Health How ACO s Can Impact Contracting A Real World Example Mike Medel Pharm D, MBA Banner Health Agenda Banner Pharmacy Services Introduction Accountable Care Organization Summary Basic Constructs of ACO Partnership

More information

DIR: Trends, Issues, and Impending Impacts

DIR: Trends, Issues, and Impending Impacts DIR: Trends, Issues, and Impending Impacts Lari Harding Vice President, Product Marketing Chris Smith, R.Ph Director, Pharmacy Business Intelligence 1 Disclosures Lari Harding is the Vice President, Product

More information

POLICY AND PROCEDURE DEPARTMENT: Pharmacy Operations

POLICY AND PROCEDURE DEPARTMENT: Pharmacy Operations PAGE: 1 of 6 SCOPE: Centene Corporate Pharmacy Solutions, Health Plan Pharmacy Departments, Centene Pharmacy and Therapeutics Committee, Health Plan Pharmacy and Therapeutics Committees, Envolve Pharmacy

More information

Lindsey Imada, PharmD Candidate 2016 Midwestern University, Chicago College of Pharmacy

Lindsey Imada, PharmD Candidate 2016 Midwestern University, Chicago College of Pharmacy Lindsey Imada, PharmD Candidate 2016 Midwestern University, Chicago College of Pharmacy Under the Preceptorship of Dr. Craig Stern Pro Pharma Pharmaceutical Consultants, Inc. September 11, 2015 S OBJECTIVES

More information

Re: Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of- Pocket Expenses [CMS-4180-P]

Re: Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of- Pocket Expenses [CMS-4180-P] January 25, 2019 Seema Verma, Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Attention: CMS-4180-P P.O. Box 8013 Baltimore, MD 21244-8013 Re: Modernizing

More information

KEEPING PRESCRIPTION DRUGS AFFORDABLE: The Value of Pharmacy Benefit Managers (PBMs)

KEEPING PRESCRIPTION DRUGS AFFORDABLE: The Value of Pharmacy Benefit Managers (PBMs) The Texas Association of Health Plans Representing health insurers, health maintenance organizations, and other related health care entities operating in Texas. KEEPING PRESCRIPTION DRUGS AFFORDABLE: The

More information

Insightsfeature. Managing Specialty Drug Spend Under the Medical Benefit. Innovations and Automation for More Effective Management.

Insightsfeature. Managing Specialty Drug Spend Under the Medical Benefit. Innovations and Automation for More Effective Management. Insightsfeature Managing Specialty Drug Spend Under the Medical Benefit Innovations and Automation for More Effective Management March 30, 2017 The Less-Visible Part of Specialty Spend By most estimates,

More information

DIR fees are knocking down pharmacy profits

DIR fees are knocking down pharmacy profits 16 America s PHARMACIST November 2016 DIR fees are knocking down pharmacy profits by Bruce A. Semingson, Pharmacist In 2016, retail pharmacy will pay between $360 million and $2.16 billion in direct and

More information

Real-Time Benefit Check (RTBC) Solution Assessment. Requirements for selecting the most valuable RTBC solution for your health system

Real-Time Benefit Check (RTBC) Solution Assessment. Requirements for selecting the most valuable RTBC solution for your health system Real-Time Benefit Check (RTBC) Solution Assessment Requirements for selecting the most valuable RTBC solution for your health system Prescription cost is the primary predictor of medication abandonment.

More information

PRESCRIPTION DRUG SPENDING IN THE U.S. HEALTH CARE SYSTEM: AN ACTUARIAL PERSPECTIVE

PRESCRIPTION DRUG SPENDING IN THE U.S. HEALTH CARE SYSTEM: AN ACTUARIAL PERSPECTIVE PRESCRIPTION DRUG SPENDING IN THE U.S. HEALTH CARE SYSTEM: AN ACTUARIAL PERSPECTIVE Moderator Audrey Halvorson, Vice Chairperson, Health Practice Council Presenters Karen Bender, Member, Prescription Drug

More information

Managing Specialty Pharmaceuticals: Balancing Access and Affordability

Managing Specialty Pharmaceuticals: Balancing Access and Affordability Managing Specialty Pharmaceuticals: Balancing Access and Affordability Commercial Health Plan Perspective The Health Industry Forum July 16, 2008 Presented by: Margaret M. (Peggy) Johnson, R.Ph. Vice President

More information

Meeting the Health Care Challenges of Tomorrow. Jon Roberts Executive Vice President & President, CVS Caremark

Meeting the Health Care Challenges of Tomorrow. Jon Roberts Executive Vice President & President, CVS Caremark Meeting the Health Care Challenges of Tomorrow Jon Roberts Executive Vice President & President, CVS Caremark Agenda PBMs: Needed Now More Than Ever Performance Highlights How We Address Payors #1 Priority:

More information

January 25, Re: Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Outof-Pocket Expenses [CMS 4180 P] RIN 0938 AT92

January 25, Re: Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Outof-Pocket Expenses [CMS 4180 P] RIN 0938 AT92 January 25, 2019 [Submitted electronically via www.regulations.gov] The Honorable Seema Verma Administrator Centers for Medicare & Medicaid Services U.S. Department of Health and Human Services Attention:

More information

10 Best Practices For Payer Contracting:

10 Best Practices For Payer Contracting: 10 Best Practices For Payer Contracting: A Roadmap for Successful Negotiations Steve Selbst Healthcents, Inc. 2016 NHIA Annual Conference & Exposition 1 Speaker Disclosures Steve Selbst is employed by

More information

10 Best Practices For Payer Contracting: A Roadmap for Successful Negotiations

10 Best Practices For Payer Contracting: A Roadmap for Successful Negotiations 10 Best Practices For Payer Contracting: A Roadmap for Successful Negotiations Steve Selbst Healthcents, Inc. Speaker Disclosures Steve Selbst is employed by a business firm that provides services related

More information

Understanding Your Prescription Program. CCIU Employee Meeting September 7, 2016

Understanding Your Prescription Program. CCIU Employee Meeting September 7, 2016 Understanding Your Prescription Program CCIU Employee Meeting September 7, 2016 Welcome to FutureScripts! Founded in 2006 Philadelphia presence Strong ties to community and local businesses 68,000 pharmacies

More information

Pharmacy Benefit Managers (PBMs)

Pharmacy Benefit Managers (PBMs) Pharmacy Benefit Managers (PBMs) Reducing Costs and Improving Quality Lauren Rowley, VP State Affairs National Conference of State Legislatures May 18, 2018 Overview What is the problem? What is a PBM?

More information

Standing strong for payers and patients

Standing strong for payers and patients Standing strong for payers and patients Eric Slusser, EVP, Chief Financial Officer Everett Neville, SVP Supply Chain and Specialty B A N K O F A M E R I C A M E R R I L L L Y N C H H E A LTH C A RE CONFERENCE

More information

Florida Medicaid Prescribed Drug Service Spending Control Initiatives. For the Quarter July 1, 2016 through September 30, 2016

Florida Medicaid Prescribed Drug Service Spending Control Initiatives. For the Quarter July 1, 2016 through September 30, 2016 Florida Medicaid Prescribed Drug Service Spending Control Initiatives For the Quarter July 1, through September 30, Report to the Florida Legislature March 2018 [This page intentionally left blank.] Table

More information

The Management of Specialty Drugs: Opportunities and Challenges

The Management of Specialty Drugs: Opportunities and Challenges The Management of Specialty Drugs: Opportunities and Challenges Scott Woods Senior Director, Policy PCMA Innovations X April 5, 2016 Specialty Drugs to be Half of Spend by 2018 Forecast PMPM Net Drug

More information

The U.S. Healthcare System: How Pharmacy Benefit Managers Impact Prescription Drug Use. Presented by Daniel Tomaszewski Pharmd, PhD

The U.S. Healthcare System: How Pharmacy Benefit Managers Impact Prescription Drug Use. Presented by Daniel Tomaszewski Pharmd, PhD The U.S. Healthcare System: How Pharmacy Benefit Managers Impact Prescription Drug Use Presented by Daniel Tomaszewski Pharmd, PhD 1 Medical Vs. Pharmacy Coverage Medical Insurance Managed by an Insurance

More information

Implement a definition of negotiated price to include all pharmacy price concessions.

Implement a definition of negotiated price to include all pharmacy price concessions. NCPA Analysis of Medicare Part D Pharmacy DIR Fee Reform Policy Proposal and Other Policies Impacting Community Pharmacies in the CMS Proposed Rule, Modernizing Part D and Medicare Advantage to Lower Drug

More information

The 2018 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

The 2018 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers The 2018 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers Adam J. Fein, Ph.D. Drug Channels Institute February 2018 Full report available at http://drugch.nl/pharmacy COPYRIGHT Copyright

More information

How Does CCNC s Model Align with Value Based Payments? Lead Community Pharmacy Coordinator CCNC V.P. Moose Pharmacy Joe Moose, PharmD

How Does CCNC s Model Align with Value Based Payments? Lead Community Pharmacy Coordinator CCNC V.P. Moose Pharmacy Joe Moose, PharmD Improving care through shared knowledge How Does CCNC s Model Align with Value Based Payments? Lead Community Pharmacy Coordinator CCNC V.P. Moose Pharmacy Joe Moose, PharmD $100 Total Healthcare Spend

More information

Farm Bureau Select Rx 2017 Summary of Benefits January 1, December 31, 2017

Farm Bureau Select Rx 2017 Summary of Benefits January 1, December 31, 2017 P.O. Box 266380 Weston, FL 33326 Farm Bureau Select Rx 2017 Summary of Benefits January 1, 2017 - December 31, 2017 Thank you for your interest in Farm Bureau Select Rx, Our plan is offered by Members

More information

THE FAST AND THE FURIOUS REVENUE CYCLE (A.K.A.) THE REVENUE CYCLE OF THE FUTURE

THE FAST AND THE FURIOUS REVENUE CYCLE (A.K.A.) THE REVENUE CYCLE OF THE FUTURE THE FAST AND THE FURIOUS REVENUE CYCLE - 3.0 (A.K.A.) THE REVENUE CYCLE OF THE FUTURE INDUSTRY ANALYSIS 82% of people say price is the most important factor when making a healthcare purchasing decision*

More information

Employee Benefit Trends and Strategies

Employee Benefit Trends and Strategies Employee Benefit Trends and Strategies Leo Tokar Executive Vice President L O C K T O N C O M P A N I E S Topics Lockton Employer Survey Market Trends What are Employers Doing? 2 Lockton Employer Survey

More information

Improving health care affordability Helping health plans bend the cost curve

Improving health care affordability Helping health plans bend the cost curve Improving health care affordability Helping health plans bend the cost curve What s at stake? After years of escalating costs, US health care has become unaffordable for many. Industry stakeholders, including

More information

Session 75 OF, Advantages & Challenges for Provider Led Health Plans. Moderator: LuCretia Leola Hydell, ASA, MAAA

Session 75 OF, Advantages & Challenges for Provider Led Health Plans. Moderator: LuCretia Leola Hydell, ASA, MAAA Session 75 OF, Advantages & Challenges for Provider Led Health Plans Moderator: LuCretia Leola Hydell, ASA, MAAA Presenters: Jerry Clark, MD, FACP Josh Martin Mark Rishell SOA Antitrust Disclaimer SOA

More information

Florida Medicaid Prescribed Drug Service Spending Control Initiatives

Florida Medicaid Prescribed Drug Service Spending Control Initiatives Florida Medicaid Prescribed Drug Service Spending Control Initiatives For the Quarters January 1, through March 31, and April 1, through June 30, Report to the Florida Legislature April 2018 [This page

More information

Best Practice Recommendation for

Best Practice Recommendation for Best Practice Recommendation for Exchanging & Processing about Pharmacy Benefit Management Version 020915a Issue Date Version Explanation 10-20-2014 First Release 02-09-15 Clarify language under Health

More information

Prescription Drug Plan Update

Prescription Drug Plan Update Prescription Drug Plan Update Kenyon College May 24, 2018 1 Plan Design Changes effective July 1, 2018 Basic Plan Current Basic Plan 7/1/2018 Premium Plan Current Premium Plan 7/1/2018 Annual Deductible

More information

SelectHealth Prescriptions

SelectHealth Prescriptions SelectHealth Prescriptions pharmacy benefit management program SM SelectHealth Prescriptions is a full-service Pharmacy Benefit Manager (PBM) that offers transparent pricing, clinically based programs,

More information

The 2019 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

The 2019 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers The 2019 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers Adam J. Fein, Ph.D. Drug Channels Institute March 2019 Full report available at https://drugch.nl/pharmacy COPYRIGHT Copyright

More information

9/23/2016. Our Services. Transitioning from Fee-for-Service to Value-based Reimbursement. Key Trends and Strategies for Rural Health Providers

9/23/2016. Our Services. Transitioning from Fee-for-Service to Value-based Reimbursement. Key Trends and Strategies for Rural Health Providers Transitioning from Fee-for-Service to Value-based Reimbursement Key Trends and Strategies for Rural Health Providers Paul MacLellan, CEO >> Health care consulting company >> Wholly owned subsidiary of

More information

Medicaid Prescription Drug Payment Reform

Medicaid Prescription Drug Payment Reform Medicaid Prescription Drug Payment Reform Spring 2006 NCSL Health Chairs Meeting John M. Coster, Ph.D., R.Ph. June 10, 2006 1 Community Retail Pharmacy In 2005, there were approximately 56,000 community

More information

Understanding PBM Quality. The 2 nd National Alliance PBM Report. John Miller

Understanding PBM Quality. The 2 nd National Alliance PBM Report. John Miller Understanding PBM Quality The 2 nd National Alliance PBM Report John Miller john.miller@mabgh.org 1 2 2 MARKET SHARE All Other 3% MedImpact 5% Prime Therapeutics 6% CVS/Caremark 25% Humana 7% Envision

More information

Disease Management and the Medicare Drug Benefit: Opportunities and Threats for the Pharmaceutical Industry

Disease Management and the Medicare Drug Benefit: Opportunities and Threats for the Pharmaceutical Industry Disease Management and the Medicare Drug Benefit: Opportunities and Threats for the Pharmaceutical Industry Jeffrey A. Bourret, M.S., R.Ph., FASHP Senior Director, Managed Markets Healthcare Systems Marketing

More information

Brian Bertha VP, Corporate Strategy and Business Development McKesson U.S. Pharmaceutical

Brian Bertha VP, Corporate Strategy and Business Development McKesson U.S. Pharmaceutical Brian Bertha VP, Corporate Strategy and Business Development McKesson U.S. Pharmaceutical 2 Safe Harbor Clause Some of the information in this presentation may constitute forwardlooking statements that

More information

Inside: Critical information about your company s prescription drug benefit.

Inside: Critical information about your company s prescription drug benefit. Inside: Critical information about your company s prescription drug benefit. Questions Company Benefits Managers Must Ask Their PBM It pays to make an informed decision harmacy Benefit Managers, often

More information

FEEL BETTER. CONNECTED.

FEEL BETTER. CONNECTED. FEEL BETTER. CONNECTED. Connected across pharmacy and medical. To take you further. Katy Wong, RPh, MBA Vice President, Producer Relations Cigna Pharmacy Management Offered by: Cigna Health and Life Insurance

More information

Farm Bureau Essential Rx 2018 Summary of Benefits January 1, December 31, 2018

Farm Bureau Essential Rx 2018 Summary of Benefits January 1, December 31, 2018 Farm Bureau Health Plans P.O. Box 266380 Weston, FL 33326 Farm Bureau Essential Rx 2018 Summary of Benefits January 1, 2018 - December 31, 2018 Thank you for your interest in Farm Bureau Essential Rx.

More information

Future Trends in Employment, Health and Labor

Future Trends in Employment, Health and Labor Future Trends in Employment, Health and Labor PRESENTED BY: Mike Wojcik, MBA,CLU,CFP Senior Vice President Public Sector Practice Group The Horton Group www.thehortongroup.com 1 Agenda Affordable Care

More information

Understanding Pharmacy Benefit Management Services

Understanding Pharmacy Benefit Management Services Understanding Pharmacy Benefit Management Services Peter Cullen VP, Business Development and Strategic Initiatives March 12, 2014 Innovation Session Overview and Learning Objectives Session Overview: Provide

More information

Subject: Pharmacy Services & Formulary Management (Page 1 of 5)

Subject: Pharmacy Services & Formulary Management (Page 1 of 5) Subject: Pharmacy Services & Formulary Management (Page 1 of 5) Objective: I. To ensure the clinically appropriate prescription and use of pharmaceuticals by Tuality Health Alliance (THA) providers and

More information

The Real Deal About Real-Time Benefits. Proven Savings with Up-to-the-Minute, Member-Specific Information Across Multiple Points of Care

The Real Deal About Real-Time Benefits. Proven Savings with Up-to-the-Minute, Member-Specific Information Across Multiple Points of Care The Real Deal About Real-Time Benefits Proven Savings with Up-to-the-Minute, Member-Specific Information Across Multiple Points of Care Cost is a key issue for plan members and a common barrier to medication

More information

Florida Medicaid Prescribed Drug Service Spending Control Initiatives. For the Quarter April 1, 2016 through June 30, 2016

Florida Medicaid Prescribed Drug Service Spending Control Initiatives. For the Quarter April 1, 2016 through June 30, 2016 Florida Medicaid Prescribed Drug Service Spending Control Initiatives For the Quarter April 1, through June 30, Report to the Florida Legislature December 2017 [This page intentionally left blank.] Table

More information

Survey Analysis of January 2014 CMS Medicare Part D Proposed Rule

Survey Analysis of January 2014 CMS Medicare Part D Proposed Rule Survey Analysis of January 2014 CMS Medicare Part D Proposed Rule Prepared for: Pharmaceutical Care Management Association Prepared by: Stephen J. Kaczmarek, FSA, MAAA Principal and Consulting Actuary

More information

(PDP) 2014 Summary of benefits for our Medicare prescription drug plans (Enhanced and Standard)

(PDP) 2014 Summary of benefits for our Medicare prescription drug plans (Enhanced and Standard) (PDP) 2014 Summary of benefits for our prescription drug plans (Enhanced and Standard) Contract S5540, Plans 004 and 002 January 1, 2014 December 31, 2014 U5073c, 8/13 Y0079_6249 CMS Accepted 09112013

More information

Medicaid Prescribed Drug Program Spending Control Initiatives. For the Quarter April 1, 2014 through June 30, 2014

Medicaid Prescribed Drug Program Spending Control Initiatives. For the Quarter April 1, 2014 through June 30, 2014 Medicaid Prescribed Drug Program Spending Control Initiatives For the Quarter April 1, 2014 through June 30, 2014 Report to the Florida Legislature January 2015 Table of Contents Purpose of Report... 1

More information

Co pays and Deductibles: Polices and Procedures

Co pays and Deductibles: Polices and Procedures Co pays and Deductibles: Polices and Procedures :, Senior Operations and Management Consultant M.T.M. Services E-mail: michael.flora@mtmservices.org Web Site: www.mtmservices.org 1 MTM Publication Ordering

More information

Medicare Part D Transition Policy CY 2018 HCSC Medicare Part D

Medicare Part D Transition Policy CY 2018 HCSC Medicare Part D Contract: H0107, H0927, H1666, H3251, H3822, H3979, H8133, H8634, H8554, S5715 Policy Name: Medicare Formulary Transition Purpose: This procedure describes the standard process Health Care Service Corporation

More information

PHARMACY BENEFIT MANAGER (PBM)

PHARMACY BENEFIT MANAGER (PBM) PHARMACY BENEFIT MANAGER (PBM) Presentation by: Pantea Ghasemi, USC Pharm.D. Candidate of 2015 Mentor: Dr. Craig Stern, Pro Pharma Consultants Inc. April 3, 2015 OBJECTIVES 1. Define PBM 2. Discuss Service

More information

Gulf Coast and LA HFMA Payer Summit Value-based contracts same healthcare business?

Gulf Coast and LA HFMA Payer Summit Value-based contracts same healthcare business? Gulf Coast and LA HFMA Payer Summit Value-based contracts same healthcare business? Richard R. Vath, MD FMOLHS SVP/Chief Clinical Transformation Officer President Health Leaders Network and Medicare ACO

More information

How Medication Adherence and Outcomes Are Changing the Business Model

How Medication Adherence and Outcomes Are Changing the Business Model How Medication Adherence and Outcomes Are Changing the Business Model Laura Cranston Executive Director Todd Sega Manager, Payer Relations Lari Harding VP, Strategy & Growth Healthcare Network 3 Session

More information

Contract Summary. OptumRx Administrative Services, LLC

Contract Summary. OptumRx Administrative Services, LLC Attachment C Contract Summary OptumRx Administrative Services, LLC Subcontractors This contract includes the following subcontractors or pass through to other providers. Name Service(s) Amount Interpreting

More information

2015 PacificSource Medicare Part D Transition Process for contracts H3864 & H4754:

2015 PacificSource Medicare Part D Transition Process for contracts H3864 & H4754: 2015 PacificSource Medicare Part D Transition Process for contracts H3864 & H4754: Essentials Rx 6 (HMO), Essentials Rx 14 (HMO), Essentials Rx 15 (HMO), Essentials Rx 16 (HMO), Essentials Rx 19 (HMO),

More information

Blue Essentials, Blue Advantage HMO SM and Blue Premier SM Provider Manual - Pharmacy

Blue Essentials, Blue Advantage HMO SM and Blue Premier SM Provider Manual - Pharmacy Blue Essentials, Blue Advantage HMO SM and Blue Premier SM Provider Manual - In this Section there are references unique to Blue Essentials, Blue Advantage HMO and Blue Premier. These network specific

More information

HPM Institute Live National Podcast: "How Brokers Can Use Technology to Help Clients Achieve Lower Health Costs and Better Health Outcomes"

HPM Institute Live National Podcast: How Brokers Can Use Technology to Help Clients Achieve Lower Health Costs and Better Health Outcomes HPM Institute Live National Podcast: "How Brokers Can Use Technology to Help Clients Achieve Lower Health Costs and Better Health Outcomes" Featured Guests: ERIK DAVIS and SCOTT HAAS, Wells Fargo Insurance

More information

Delivering Value for All Health Care Stakeholders. Larry Merlo President & Chief Executive Officer

Delivering Value for All Health Care Stakeholders. Larry Merlo President & Chief Executive Officer Delivering Value for All Health Care Stakeholders Larry Merlo President & Chief Executive Officer Agenda Our Value Proposition Has Never Been Stronger We See Compelling Opportunities in a Robust Health

More information

The Health Insurance Market in Virginia. Maureen Dempsey, MD, MSc, ACC, FAAP Anthem Blue Cross and Blue Shield June 8, 2017

The Health Insurance Market in Virginia. Maureen Dempsey, MD, MSc, ACC, FAAP Anthem Blue Cross and Blue Shield June 8, 2017 The Health Insurance Market in Virginia Maureen Dempsey, MD, MSc, ACC, FAAP Anthem Blue Cross and Blue Shield June 8, 2017 Anthem Inc. at a Glance Broad geographic footprint and customer base ` BCBS plans

More information

MEDICARE PART D POLICY FORMULARY: TRANSITION PROCESS Policy Number: 6-C

MEDICARE PART D POLICY FORMULARY: TRANSITION PROCESS Policy Number: 6-C MEDICARE PART D POLICY FORMULARY: TRANSITION PROCESS Policy Number: 6-C Coverage Statement This Policy is applicable to: Medco PDP, Beneficiaries, Enhanced PDPs, Client PDPs and Client MA-PDs, to the extent

More information

Clinically Integrated Networks and Population Health The next chapter in healthcare

Clinically Integrated Networks and Population Health The next chapter in healthcare Clinically Integrated Networks and Population Health The next chapter in healthcare M A T T H E W M A T U S I A K, D H S C, F R I P H ( UK) M T ( A S C P ) Health System Challenges While the Uninsured

More information

Investor Conference. Health Net Pharmaceutical Services

Investor Conference. Health Net Pharmaceutical Services Investor Conference Health Net Pharmaceutical Services John Sivori President, Health Net Pharmaceutical Services December 13, 2006 Health Net Pharmaceutical Services: What We Do HNPS (HNT s PBM) manages

More information

Today PBMs control the pharmacy benefits of more than 253 MILLION Americans.

Today PBMs control the pharmacy benefits of more than 253 MILLION Americans. The PBM Story Decades ago, insurance companies expanded their coverage to include prescription drugs. They turned to a new kind of company, a sort of middleman, to process prescription drug claims. For

More information

Today PBMs control the pharmacy benefits of more than 253 MILLION. 3 PBMs. Americans.

Today PBMs control the pharmacy benefits of more than 253 MILLION. 3 PBMs. Americans. The PBM Story Decades ago, insurance companies expanded their coverage to include prescription drugs. They turned to a new kind of company, a sort of middleman, to process prescription drug claims. For

More information

Evaluation of Savings from Pharmaceutical Interventions. Robin Lunge Steve Kappel January 26, 2007

Evaluation of Savings from Pharmaceutical Interventions. Robin Lunge Steve Kappel January 26, 2007 Evaluation of Savings from Pharmaceutical Interventions Robin Lunge Steve Kappel January 26, 2007 Ways to Achieve Savings Any effort to address savings must have an effect on prices, utilization, or intensity,

More information

Contract Summary. OptumRx Administrative Services, LLC

Contract Summary. OptumRx Administrative Services, LLC Contract Summary OptumRx Administrative Services, LLC Subcontractors This contract includes the following subcontractors or pass through to other providers. Name Service(s) Amount Interpreting Services

More information

THANK YOU SPONSORS 2

THANK YOU SPONSORS 2 1 THANK YOU SPONSORS 2 How to: Power Up your pharmacy benefit plan Brent Matthews, Benefits Advisor/Principal, TrueNorth Companies Aaron Viertel, Director of Clinical Management, TrueNorth Companies 3

More information

2019 Transition Policy

2019 Transition Policy 2019 Number: 5.8 Prescription Drug Replaces: 5.8 v.2018 Cross 5.1.2 Transition Fill Monitoring Procedure References: Purpose: To provide guidance on the transition process for new or current Plan members

More information

Marc Claussen, Chiesi USA, Director, Market Access. Donna White, Chiesi USA, Sr. Director, Contracting and Compliance

Marc Claussen, Chiesi USA, Director, Market Access. Donna White, Chiesi USA, Sr. Director, Contracting and Compliance Marc Claussen, Chiesi USA, Director, Market Access Donna White, Chiesi USA, Sr. Director, Contracting and Compliance The views/observations expressed in this presentation are the personal views/observations

More information

2012 Medicare Part D Transition Process for contracts H3864 & H4754:

2012 Medicare Part D Transition Process for contracts H3864 & H4754: 2012 Medicare Part D Transition Process for contracts H3864 & H4754: Essentials Rx 6, Essentials Rx 14, Essentials Rx 15, Essentials Rx 16, Premier Rx 7, Explorer Rx 1, Explorer Rx 2, and Explorer Rx 4

More information

Glossary of Terms (Terms are listed in Alphabetical Order)

Glossary of Terms (Terms are listed in Alphabetical Order) Glossary of Terms (Terms are listed in Alphabetical Order) Access Access refers to the availability and location of pharmacies that participate in the network that serves your pharmacy benefit plan. Acute

More information

Optum. Actuarial Toolbox Proven, sophisticated and market-leading actuarial models for health plans and benefits consultants

Optum. Actuarial Toolbox Proven, sophisticated and market-leading actuarial models for health plans and benefits consultants Optum Actuarial Toolbox Proven, sophisticated and market-leading actuarial models for health plans and benefits consultants In recent years, the health care landscape has shifted tremendously, prompting

More information

What to Expect for Pharmacy Benefits and Drug Cost Trends for 2018 & 2019

What to Expect for Pharmacy Benefits and Drug Cost Trends for 2018 & 2019 What to Expect for Pharmacy Benefits and Drug Cost Trends for 2018 & 2019 Mid-Sized Retirement and Healthcare Plan Management Conference 2018. Innovative Rx Strategies, LLC. All rights reserved. The Ever

More information

summary of benefits Blue Shield of California Medicare Rx Plan (PDP)

summary of benefits Blue Shield of California Medicare Rx Plan (PDP) summary of benefits Blue Shield of California Medicare Rx Plan (PDP) An employer-sponsored Medicare Prescription Drug Plan for City and County of San Francisco retirees, spouses and eligible dependents

More information

BERKELEY RESEARCH GROUP. Executive Summary

BERKELEY RESEARCH GROUP. Executive Summary Executive Summary Within the U.S. healthcare system, the flow of dollars in the pharmaceutical marketplace is a complex process involving a variety of stakeholders and myriad rebates, discounts, and fees

More information

Amerigroup Medicare Member PBM Conversion Talking Points

Amerigroup Medicare Member PBM Conversion Talking Points Amerigroup Medicare Member PBM Conversion Talking Points Overview On January 1, 2015, pharmacy benefits for L-Amerigroup Amerivantage (AMV) members will be covered through Express Scripts, Inc. (ESI).

More information

August 4, The Honorable Charles Rangel, Chairman Committee on Ways and Means United States House of Representatives Washington, D.C.

August 4, The Honorable Charles Rangel, Chairman Committee on Ways and Means United States House of Representatives Washington, D.C. August 4, 2009 The Honorable Charles Rangel, Chairman Committee on Ways and Means United States House of Representatives Washington, D.C. 20515 The Honorable Henry A. Waxman, Chairman Committee on Energy

More information

MACRAnomics. Patient-Level Economics and Strategic Implications for Providers. Presented to: NW Ohio HFMA October 20, 2016

MACRAnomics. Patient-Level Economics and Strategic Implications for Providers. Presented to: NW Ohio HFMA October 20, 2016 MACRAnomics Patient-Level Economics and Strategic Implications for Providers Presented to: NW Ohio HFMA October 20, 2016 Property of HealthScape Advisors Strictly Confidential 2 MACRAnomics: Objectives

More information

https://survey.mercer.com/forms/surveys/preview.aspx?print=default&s=3779&loc=en-...

https://survey.mercer.com/forms/surveys/preview.aspx?print=default&s=3779&loc=en-... Page 1 of 21 Page 1 Purpose of This Survey The Tennessee Department of Finance and Administration (TennCare) engaged Mercer Government Human Services Consulting (Mercer), part of Mercer Health & Benefits

More information

Welcome. AMCP Partnership Forum. Designing Benefits and Payment Models for Innovative High Investment Medications

Welcome. AMCP Partnership Forum. Designing Benefits and Payment Models for Innovative High Investment Medications AMCP Partnership Forum Designing Benefits and Payment Models for Innovative High Investment Medications Welcome Bri Palowitch, PharmD, BCGP Manager, Pharmacy Affairs Academy of Managed Care Pharmacy Disclaimer

More information

A VISIBLY DIFFERENT APPROACH TO PHARMACY BENEFITS FOR EMPLOYERS

A VISIBLY DIFFERENT APPROACH TO PHARMACY BENEFITS FOR EMPLOYERS A VISIBLY DIFFERENT APPROACH TO PHARMACY BENEFITS FOR EMPLOYERS AN INNOVATIVE IDEA THAT CHANGED THE INDUSTRY In 2001, frustrated by the limitations and lack of transparency in the traditional pharmacy

More information

Third Quarter 2017 Earnings Conference Call

Third Quarter 2017 Earnings Conference Call Third Quarter 2017 Earnings Conference Call Larry Merlo President & Chief Executive Officer Dave Denton Executive Vice President & Chief Financial Officer November 6, 2017 Forward-looking Statements This

More information

June Investor Presentation

June Investor Presentation June 2014 Investor Presentation Safe Harbor Certain statements included herein, including guidance and those that express management's objectives and the strategies to achieve those objectives, as well

More information

Summary of Benefits. Regence Medicare Script TM. Enhanced (PDP) Basic (PDP) Medicare Prescription Drug Plan for Utah

Summary of Benefits. Regence Medicare Script TM. Enhanced (PDP) Basic (PDP) Medicare Prescription Drug Plan for Utah 2013 Summary of Benefits Medicare Prescription Drug Plan for Utah Regence Medicare Script TM Enhanced (PDP) Regence Medicare Script TM Basic (PDP) Regence BlueCross BlueShield of Utah is an Independent

More information

Prescription Drug Pricing and Community Pharmacy NALEO Legislative Summit on Health October 21, 2017

Prescription Drug Pricing and Community Pharmacy NALEO Legislative Summit on Health October 21, 2017 Prescription Drug Pricing and Community Pharmacy NALEO Legislative Summit on Health October 21, 2017 Ronna Hauser, PharmD VP Pharmacy Affairs The strength of our numbers NCPA represents America's 22,000+

More information

Plunging into PBM Pricing Spread to Create Client Centric Contracts

Plunging into PBM Pricing Spread to Create Client Centric Contracts Plunging into PBM Pricing Spread to Create Client Centric Contracts Scott Haas, Vice President Integrated Healthcare Metrics SIIA 32 nd Annual National Educational Conference & Expo October 2, 2012 Wells

More information

Support and pass provider status legislation in the House and Senate (H.R. 592/S. 109).

Support and pass provider status legislation in the House and Senate (H.R. 592/S. 109). ISSUES Preserve beneficiary access to pharmacy services provided to Medicaid, Medicare and commercially-insured patients as Congress continues to debate health care policy. Support and pass provider status

More information

Pharmacy Program Management: Pitfalls, Challenges, and Best Practices About Solid Benefit Guidance specialty 60,000,000 covered member lives INSIDER

Pharmacy Program Management: Pitfalls, Challenges, and Best Practices About Solid Benefit Guidance specialty 60,000,000 covered member lives INSIDER Pharmacy Program Management: Pitfalls, Challenges, and Best Practices October 2, 2017 This presentation contains proprietary information and is not to be reproduced or further distributed without permission

More information

CIS Responses to Vendor Questions PBM RFP September 23, 2015 Addendum #1

CIS Responses to Vendor Questions PBM RFP September 23, 2015 Addendum #1 CIS Responses to Vendor Questions PBM RFP September 23, 2015 Addendum #1 A. BACKGROUND On September 4, 2015, CIS issued a Request for Proposals (RFP) for pharmacy benefit management services. CIS is issuing

More information

Health care affordability Opportunity assessment

Health care affordability Opportunity assessment Health care affordability Opportunity assessment Health care affordability Opportunity assessment Hidden in plain sight 30 percent of health care spend is unnecessary. 1 Are you looking in the right places

More information

Pharmacy Acquisition Cost and Its Role in Contract Negotiating

Pharmacy Acquisition Cost and Its Role in Contract Negotiating Pharmacy Acquisition Cost and Its Role in Contract Negotiating Presented by: Todd Grover Glass Box Analytics August 23, 2017 Understanding Pharmacy Acquisition Cost (AC) Drives Relationship Pairs Pharmacy

More information

Standing strong for payers and patients

Standing strong for payers and patients Standing strong for payers and patients Dr. Steve Miller, SVP, Chief Medical Officer Ben Bier, VP Investor Relations W I L L I A M B L A I R 3 7 TH ANNUAL G ROWTH STOCK C ONFERENCE 6.14.17 1 Safe harbor

More information

Avalere Health 2015 Industry Outlook

Avalere Health 2015 Industry Outlook 2015 Industry Outlook 2 Introduction Industry Outlook 2015 Changes in healthcare financing, delivery, and organization are transforming the sector. Health plans and providers are revising their business

More information

Pharmacy/Prescriber Medicaid Managed Care Network & Medicaid Provider Enrollment. February 14, 2018

Pharmacy/Prescriber Medicaid Managed Care Network & Medicaid Provider Enrollment. February 14, 2018 Pharmacy/Prescriber Medicaid Managed Care Network & Medicaid Provider Enrollment February 14, 2018 2 Pharmacy/ Prescriber Enrollment Enrollment Effective Date Pharmacy/Prescriber FAQ s Contract Amendment

More information